INTRODUCTION Several novel variants of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), the virus that causes COVID-19, emerged in late 2020. One of these, …

Background An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has led to 95 333 confirmed cases as of March 5, 2020. Understanding the early …

Background Isolation of cases and contact tracing is used to control outbreaks of infectious
diseases, and has been used for coronavirus disease 2019 (COVID-19). Whether this …

Background In December, 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
a novel coronavirus, emerged in Wuhan, China. Since then, the city of Wuhan has …

Background The risk of severe COVID-19 if an individual becomes infected is known to be
higher in older individuals and those with underlying health conditions. Understanding the …

Background The isolation of symptomatic cases and tracing of contacts has been used as
an early COVID-19 containment measure in many countries, with additional physical …

Background Non-pharmaceutical interventions have been implemented to reduce transmission
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the UK. Projecting …

Background To mitigate and slow the spread of COVID-19, many countries have adopted
unprecedented physical distancing policies, including the UK. We evaluate whether these …

A novel SARS-CoV-2 variant, VOC 202012/01, emerged in southeast England in November
2020 and is rapidly spreading towards fixation. Using a variety of statistical and dynamic …

Background National immunisation programmes globally are at risk of suspension due to the
severe health system constraints and physical distancing measures in place to mitigate the …